Investor News | FSE
Fresenius Kabi - Canadian Digestive Health Foundation
Fresenius Kabi recalls Ivenix Infusion System over leaks that delay, interrupt therapy
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases - The Lancet Gastroenterology & Hepatology
Low Risk for IBD Relapse After Switch From IV to Subcutaneous Infliximab | MedPage Today
JCM | Free Full-Text | Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic
Ulcerative Colitis: Today, Tomorrow, and the Future - European Medical Journal
Diagnosis, Management, and Monitoring of IBD: Early Diagnosis and Individualizing Therapy | CCO
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial - The Lancet Gastroenterology & Hepatology
Fresenius Kabi receives U.S. FDA approval for biosimilar Idacio® (adalimumab) - Fresenius Kabi Global
Nutrients | Free Full-Text | The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management
Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative Colitis | MedPage Today
Fresenius Kabi secures US FDA approval for its adalimumab biosimilar
Review article: randomised controlled trials in inflammatory bowel disease—common challenges and potential solutions - Schreiber - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
TDM and T2T – Perfect Partners? - European Medical Journal
Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management? - ScienceDirect
Fresenius Kabi - Visit the Fresenius Kabi booth at the ECCO Virtual Congress 2021 from July 8 – 10 and learn more about biosimilars, our commitment to helping more patients access biologics,
CDHF Talks: Dietary Updates and Recommendations for the IBD Patient on a Biosimilar - Canadian Digestive Health Foundation
PDF) Systematic Review and Meta-analysis on the Incidence, Prevalence and Determinants of Discomfort in Inflammatory Bowel Disease Systematic Review and Meta-analysis on the Incidence, Prevalence and Determinants of Discomfort in Inflammatory Bowel
Inflammation and malnutrition in inflammatory bowel disease - The Lancet Gastroenterology & Hepatology
Fresenius Kabi recalls newly acquired infusion pump system
Frontiers | Long-Term Overconsumption of Fat and Sugar Causes a Partially Reversible Pre-inflammatory Bowel Disease State
JCM | Free Full-Text | Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease - Rodríguez‐Lago - 2023 - United European Gastroenterology Journal - Wiley Online Library
PROJECT
Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?
Fresenius Kabi UK Events (@FreseniusKabiGB) / Twitter
